(Q46169188)

20 December 2017

title

Exploratory analysis of neuropsychological and neuroanatomical correlates of progressive mild cognitive impairment in Parkinson's disease (English)

1 reference

20 December 2017

mild cognitive impairment

1 reference

1 reference

1 reference

based on heuristic

inferred from title

cognitive dysfunction

1 reference

7

Phil Hyu Lee

1 reference

20 December 2017

Ji E Lee

1

1 reference

20 December 2017

Kyoo H Cho

2

1 reference

20 December 2017

Sook K Song

3

1 reference

20 December 2017

Hee Jin Kim

4

1 reference

20 December 2017

Hye Sun Lee

5

1 reference

20 December 2017

Young H Sohn

6

1 reference

20 December 2017

language of work or name

English

0 references

publication date

4 July 2013

1 reference

20 December 2017

Journal of Neurology, Neurosurgery and Psychiatry

published in

1 reference

20 December 2017

volume

85

1 reference

20 December 2017

issue

1

1 reference

20 December 2017

page(s)

7-16

1 reference

20 December 2017

Mild cognitive impairment: ten years later

cites work

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-305062

Defining mild cognitive impairment in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-305062

Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-305062

Neuropsychological prediction of conversion to Alzheimer disease in patients with mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-305062

Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-305062

The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-305062

Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-305062

Neuropsychological characteristics of preclinical dementia in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-305062

Neuropsychological prediction of dementia in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-305062

Memory and executive function impairment predict dementia in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-305062

Cerebral glucose metabolic features of Parkinson disease and incident dementia: longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-305062

Dementia associated with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-305062

Cholinergic correlates of cognitive impairment in Parkinson's disease: comparisons with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-305062

Dementia in Parkinson disease: functional imaging of cholinergic and dopaminergic pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-305062

Diagnostic procedures for Parkinson's disease dementia: recommendations from the movement disorder society task force

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-305062

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-305062

Prevalence of depression in Parkinson's disease: effects of disease stage, motor subtype and gender.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-305062

The pattern of cortical atrophy in patients with Parkinson's disease according to cognitive status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-305062

Abnormal integrity of corticocortical tracts in mild cognitive impairment: a diffusion tensor imaging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-305062

Mild cognitive impairment: clinical characterization and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-305062

An Inventory for Measuring Depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-305062

Clinical diagnostic criteria for dementia associated with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-305062

A fast diffeomorphic image registration algorithm

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-305062

MRI-based volumetric measurement of the substantia innominata in amnestic MCI and mild AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-305062

Mapping of brain acetylcholinesterase alterations in Lewy body disease by PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-305062

Cognitive functions of the basal forebrain

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-305062

Evolution of cognitive dysfunction in an incident Parkinson's disease cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-305062

Alpha-synuclein-immunoreactive cortical Lewy bodies are associated with cognitive impairment in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-305062

Cognitive correlates of cortical cholinergic denervation in Parkinson's disease and parkinsonian dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-305062

Olfactory dysfunction, central cholinergic integrity and cognitive impairment in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-305062

Subtypes of mild cognitive impairment in Parkinson's disease: progression to dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-305062

How do you feel--now? The anterior insula and human awareness

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-305062

Psychophysiology of neural, cognitive and affective integration: fMRI and autonomic indicants

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-305062

Neuropathology of Parkinson's disease dementia and dementia with Lewy bodies with reference to striatal pathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-305062

Striatal beta-amyloid deposition in Parkinson disease with dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-305062

Mechanisms of hybrid oligomer formation in the pathogenesis of combined Alzheimer's and Parkinson's diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-305062

Differences in neuropathologic characteristics across the Lewy body dementia spectrum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-305062

Imaging beta-amyloid burden in aging and dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-305062

Heterogeneous neuropathological findings in Parkinson's disease with mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-305062

CSF amyloid-beta and tau proteins, and cognitive performance, in early and untreated Parkinson's disease: the Norwegian ParkWest study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-305062

CSF Aβ(42) and tau in Parkinson's disease with cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-305062

CSF amyloid {beta} 1-42 predicts cognitive decline in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-305062

[(11)C]PIB-, [(18)F]FDG-PET and MRI imaging in patients with Parkinson's disease with and without dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-305062

Association between mild parkinsonian signs and mild cognitive impairment in a community.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-305062

Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-305062

Pentagon drawing and neuropsychological performance in Dementia with Lewy Bodies, Alzheimer's disease, Parkinson's disease and Parkinson's disease with dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-305062

Volumetric analysis of the substantia innominata in patients with Parkinson's disease according to cognitive status

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-305062

21 January 2018

Identifiers

DOI

10.1136/JNNP-2013-305062

1 reference

20 December 2017

PubMed ID

23828835

1 reference

20 December 2017